marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-03-2022
Abiomed Balance Sheet 2011-2024 | ABMD
Annual Balance Sheet Abiomed
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-227 M | -192 M | -121 M | -43 M | -22.7 M | -48.2 M | -22.4 M | -20.9 M | -9.45 M | -5.99 M | -5.83 M |
Long Term Debt |
3.66 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
2.46 M | 3.67 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 19.1 M | 11.5 M | 12.2 M | 28.7 M | 8.62 M | 7.49 M | 6.64 M | 5.86 M | 5.2 M | 4.5 M |
Total Current Liabilities |
129 M | 132 M | 106 M | 84.7 M | 69.6 M | 46.5 M | 39.3 M | 30.4 M | 27.1 M | 22.4 M | - |
Total Liabilities |
165 M | 151 M | 117 M | 96.9 M | 98.3 M | 55.2 M | 46.8 M | 37.1 M | 32.9 M | 27.6 M | 26.8 M |
Deferred Revenue |
24.3 M | 19.1 M | 16.4 M | 15 M | 10.5 M | 8.78 M | 7.04 M | 4.77 M | 4.2 M | 3.02 M | 1.98 M |
Retained Earnings |
828 M | 602 M | 399 M | 140 M | -47 M | -99.1 M | -137 M | -251 M | -258 M | -273 M | -275 M |
Total Assets |
1.49 B | 1.22 B | 1.05 B | 786 M | 550 M | 424 M | 338 M | 205 M | 170 M | 154 M | 132 M |
Cash and Cash Equivalents |
233 M | 192 M | 121 M | 43 M | 39 M | 48.2 M | 22.4 M | 20.9 M | 9.45 M | 5.99 M | 5.83 M |
Book Value |
1.33 B | 1.07 B | 937 M | 690 M | 452 M | 369 M | 292 M | 168 M | 137 M | 126 M | 105 M |
Total Shareholders Equity |
1.33 B | 1.07 B | 937 M | 690 M | 529 M | 369 M | 292 M | 168 M | 137 M | 126 M | 105 M |
All numbers in USD currency
Quarterly Balance Sheet Abiomed
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | 6.62 M | 6.45 M | 3.3 M | 3.53 M | 3.66 M | 7.61 M | 7.81 M | 8.37 M | 3.66 M | 9.51 M | 9.44 M | 11.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 157 M | - | 170 M | 160 M | 145 M | 151 M | 165 M | 167 M | 146 M | 148 M | 151 M | 150 M | 133 M | 122 M | 117 M | 106 M | 94.2 M | 88.7 M | 96.9 M | 87.1 M | 89.8 M | 85.2 M | 98.3 M | 83.6 M | 76.5 M | 52 M | 55.2 M | 46.1 M | 42.3 M | 44 M | 46.8 M | 45.1 M | 40 M | 35.8 M | 37.1 M | 32.9 M | 30.3 M | 29.2 M | 32.9 M | 29 M | 25.2 M | 24.4 M | 27.6 M | 22.8 M | 20.2 M | 20 M | 26.8 M |
Deferred Revenue |
- | 26 M | - | 26.4 M | 24.9 M | 24.1 M | 24.1 M | 24.3 M | 21.3 M | 21.3 M | 19.9 M | 19.1 M | 19.2 M | 19.3 M | 16.2 M | 16.4 M | 15.1 M | 14 M | 12.1 M | 15 M | 11.8 M | 10.6 M | 9.7 M | 10.5 M | 9 M | 9.1 M | 8.59 M | 8.78 M | 6.91 M | 6.8 M | 7.87 M | 7.04 M | 6.6 M | 5.76 M | 5.2 M | 4.77 M | 4.35 M | 4.14 M | 3.99 M | 4.2 M | 3.1 M | 2.9 M | 2.69 M | 3.02 M | 1.89 M | 1.82 M | 1.72 M | 1.98 M |
Retained Earnings |
- | 1.13 B | - | 965 M | 904 M | 858 M | 801 M | 828 M | 771 M | 709 M | 647 M | 602 M | 571 M | 501 M | 488 M | 399 M | 326 M | 281 M | 231 M | 140 M | 104 M | 90.2 M | 65.7 M | -47 M | -61.9 M | -77.3 M | -86.2 M | -99.1 M | -110 M | -121 M | -128 M | -137 M | -236 M | -249 M | -253 M | -251 M | -255 M | -259 M | -260 M | -258 M | -262 M | -265 M | -270 M | -273 M | -276 M | -279 M | -279 M | -275 M |
Total Assets |
- | 1.7 B | - | 1.67 B | 1.59 B | 1.53 B | 1.46 B | 1.49 B | 1.43 B | 1.33 B | 1.25 B | 1.22 B | 1.2 B | 1.12 B | 1.13 B | 1.05 B | 957 M | 887 M | 812 M | 786 M | 720 M | 695 M | 652 M | 550 M | 501 M | 475 M | 429 M | 424 M | 392 M | 373 M | 352 M | 338 M | 241 M | 216 M | 206 M | 205 M | 193 M | 181 M | 170 M | 170 M | 165 M | 166 M | 155 M | 154 M | 141 M | 132 M | 131 M | 132 M |
Cash and Cash Equivalents |
- | 182 M | - | 133 M | 144 M | 242 M | 175 M | 233 M | 181 M | 202 M | 215 M | 192 M | 118 M | 150 M | 101 M | 121 M | 84.2 M | 76.4 M | 61.3 M | 43 M | 50.5 M | 44.5 M | 44 M | 39 M | 61.1 M | 54.7 M | 38.3 M | 48.2 M | 53.2 M | 54.4 M | 40.4 M | 22.4 M | 19.5 M | 17.5 M | 34.7 M | 20.9 M | 22.6 M | 10.1 M | 11.7 M | 9.45 M | 10.8 M | 4.5 M | 3.99 M | 5.99 M | 5.09 M | 5.34 M | 4.15 M | 5.83 M |
Book Value |
- | 1.54 B | - | 1.5 B | 1.43 B | 1.38 B | 1.31 B | 1.33 B | 1.26 B | 1.18 B | 1.1 B | 1.07 B | 1.05 B | 991 M | 1 B | 937 M | 852 M | 793 M | 723 M | 690 M | 632 M | 605 M | 567 M | 452 M | 417 M | 398 M | 377 M | 369 M | 346 M | 331 M | 308 M | 292 M | 196 M | 176 M | 170 M | 168 M | 160 M | 151 M | 141 M | 137 M | 136 M | 141 M | 131 M | 126 M | 118 M | 111 M | 111 M | 105 M |
Total Shareholders Equity |
- | 1.54 B | 1.54 B | 1.5 B | 1.43 B | 1.38 B | 1.31 B | 1.31 B | 1.26 B | 1.26 B | 1.18 B | 1.1 B | 1.05 B | 1.05 B | 991 M | 1 B | 852 M | 852 M | 793 M | 690 M | 632 M | 605 M | 567 M | 452 M | 417 M | 398 M | 377 M | 369 M | 346 M | 331 M | 308 M | 292 M | 196 M | 176 M | 170 M | 168 M | 160 M | 151 M | 141 M | 137 M | 136 M | 141 M | 131 M | 126 M | 118 M | 111 M | 111 M | 105 M |
All numbers in USD currency